Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Spark Therap (NQ: ONCE )

N/A USD UNCHANGED
Last Price Updated: 12:31 PM EST, Dec 17, 2019 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Spark Therap

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Better Buy: Editas Medicine vs. CRISPR Therapeutics
Both of these gene-editing stocks are appealing, but which one reigns supreme? 
Tags SGMO GILD EDIT
From Motley Fool
A Perspective On Biopharma's Record M&A Run In 2019
This year was a watershed one for biopharma M&A, with several multibillion-dollar deals announced thus far. M&A activity in ... 
Tags SNY BMY THOR
From Benzinga
Is Editas Medicine a Buy?
The good, the bad, and the ugly behind this gene-editing stock. 
Tags ONCE Market News SGMO
From Motley Fool
Regulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition
Roche Holding has received approval from the Federal Trade Commission and Britain’s Competition and Markets Authority to acquire Spark Therapeutics, Inc. the companies announced Tuesday. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Tuesday: 
Tags companyNews
From Reuters: Company News
Regulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition
Roche Holding (OTCQX: RHHBY) has received approvalfrom the Federal Trade Commission and Britain’s Competition and Markets ... 
Tags News gene therapy Biotech
From Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags AXSM MIRM DCPH
From Benzinga
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Tuesday: 
Tags companyNews
From Reuters: Company News
UPDATE 3-Roche to complete $4.3 bln Spark deal as regulators give all clear
* Deal clears way for Roche's entry into gene therapy (Recasts to focus on Roche completing deal, adds details) 
Tags companyNews
From Reuters: Company News
Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday
Swiss drugmaker Roche Holding plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics, it said, after winning U.S. regulatory approval for the long-delayed deal. 
Tags companyNews
From Reuters: Company News
UPDATE 2-U.S. approves Roche's $4.3 billion purchase of Spark Therapeutics
Swiss drugmaker Roche has won U.S. antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics clearing the way for Roche's push into treating rare diseases including... 
Tags companyNews
From Reuters: Company News
UPDATE 1-U.S. approves Roche's $4.3 bln purchase of Spark Therapeutics
Swiss drugmaker Roche has won U.S. antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics clearing the way for the Swiss drugmaker's push into treating rare... 
Tags companyNews
From Reuters: Company News
US antitrust enforcers give Roche approval to buy Spark Therapeutics
Swiss drugmaker Roche has won U.S. antitrust approval for its $4.3 billion deal to buy gene therapy specialist Spark Therapeutics, the Federal Trade Commission said on Monday, clearing the way for the... 
Tags companyNews
From Reuters: Company News
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Monday: 
Tags companyNews
From Reuters: Company News
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday: 
Tags companyNews
From Reuters: Company News
UPDATE 1-Roche clears UK hurdle in $4.3 bln Spark deal, U.S. review drags on
Swiss drugmaker Roche won clearance from Britain's Competition and Markets Authority (CMA) on Monday for its planned $4.3 billion takeover of gene therapy company Spark Therapeutics, while a similar... 
Tags companyNews
From Reuters: Company News
Roche wins UK clearance for $4.3 bln Spark takeover as U.S. review continues
Swiss drugmaker Roche won clearance from Britain's Competition and Markets Authority for its $4.3 billion takeover of gene therapy company Spark Therapeutics, the London Stock Exchange said on Monday,... 
Tags companyNews
From Reuters: Company News
Noteworthy Friday Option Activity: ITCI, ONCE, FFIV
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Intra-Cellular Therapies Inc (ITCI), where a total volume of 8,484 contracts has... 
Tags Stocks
From Market News Video
Biotech Stocks Burn A Hole In Big Pharma's Pocket. Look For More In 2020
Mergers and acquisitions have lit up biotech stocks, and the hot pace shows no sign of slowing in 2020. Gene therapy and oncology companies are targets. 
From Investor's Business Daily
Spark Therapeutics Larger Than S&P 500 Component Affiliated Managers Group
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Spark Therapeutics Inc (ONCE) was identified as having a larger market cap than the smaller end of the S&P... 
Tags Stocks
From Market News Video
UPDATE 2-European shares dragged down by Tullow Oil and weak China export data
* Osram soars after speculation AMS might make higher offer (Updates to close, adds comments from asset managers) 
Tags companyNews
From Reuters: Company News
European stocks struggle, with drugmakers weaker and Tullow Oil plunging
European stocks were off to a weak start on Monday, as investors appeared to pause after gains late last week triggered by stronger-than-expected U.S. jobs data. 
Tags Medical Products FR:SAN Health/Care
From MarketWatch
Roche extends tender offer for Spark Therapeutics
The period for Roche’s offer of $114.50 per share for U.S.-based Spark has been extended several times and was set to expire on Dec. 10. 
Tags Markets/Exchanges ONCE Market News
From MarketWatch
Swiss drugmaker Roche again extends $4.3 bln Spark offer until Dec. 16
Swiss drugmaker Roche again extended its offer for shares of gene therapy specialist Spark Therapeutics to Dec. 16 as a regulatory review of the $4.3 billion transaction drags on. 
Tags companyNews
From Reuters: Company News
Noteworthy Thursday Option Activity: CLDR, ONCE, OMER
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cloudera Inc (CLDR), where a total of 21,611 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Here's Why uniQure Is Rallying 13% Today
Investor optimism is surging following recent M&A in gene therapy. 
Tags BOLD ALPMY Market News
From Motley Fool
The Gene Therapy Names Moving On The Audentes Buyout Deal
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD) announced a deal late Monday to be acquired by Japanese pharma company ... 
Tags ABEO BMRN SRPT
From Benzinga
Astellas’ $3 billion gene therapy deal steadies investors after stalled Roche acquisition
Astellas Pharma Inc.’s $3 billion acquisition of Audentes Therapeutics is a strong indicator that the pharmaceutical industry’s march into gene therapy development isn’t going to slow down in 2020. 
Tags Health/Care General Company Announcements
From MarketWatch
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit ... 
Tags MGNX M&A Market News
From Benzinga
Deals of the day-Mergers and acquisitions
The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Friday: 
Tags companyNews
From Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account